Europe Healthcare 3D Printing Market size surpassed USD 660.8 million in 2021 and is anticipated to expand at a CAGR of 22.1% from 2022 to 2028.

Healthcare 3D printing or medical 3D printing is an additive process whereby layers of material are built up to create a 3D part. The 3D printing is used to create living human cells or tissue for use in regenerative medicine and tissue engineering. The widely prominent key applications of healthcare 3D printing include orthopedic implants, personalized surgery, and dental devices, among others

Get more details on this report - Request Free Sample PDF

The healthcare 3D printing market growth in Europe is owing to the increasing number of applications in the medical as well as pharmacology field. Also, introduction of new technology and development of 3D printing technology. The technology has enabled 3D printing to create layers of human skin sustaining the lives of individuals that have met with critical accidents and suffering through major injuries. Moreover, increasing demand for customizations in implants for surgical procedures significantly contributes to the market growth.

Furthermore, significant interest is observed from the private and public authorities in the 3D printing marketplace and considerable amounts of funds are granted to manufacturers under various programs. For instance, in April 2022, the European Union’s invested nearly EURO 2.0 million under the REACT-EU scheme to accelerate two research projects on producing medicine and implants with a 3D printing and artificial intelligence at the University Hospital Hamburg-Eppendorf (UKE).

Europe Market, By Product

The syringe-based segment in the Europe healthcare 3D printing market accounted for USD 274.1 million revenue in 2021. The syringe-based 3D-printer, in combination with suitable materials, can reduce the delay between design and prototype and simplify fabrication of microsystems. Deposition rate of flow of material, initial and final pressure released on material during printing process are effective parameters controlled by syringe-based 3D printers. Furthermore, extensive use of 3D printers in the field of bioprinting and embedded printing have surged the segment growth considerably.

Europe Healthcare 3D Printing Market, By Technology

The fused deposition modelling (FDM) segment will reach USD 1.1 billion revenue by 2028, owing to the widespread applications in areas such as, healthcare, biomedical owing to its enhanced chemical and high heat endurance. In addition, the increased adoption of droplet deposition and its application areas such as, implants, tissue engineering, study of clinical devices as well as external wearable devices have led further expansion and market size growth of FDM technology in 3D printing for healthcare.

Europe Market, By Application

The medical application segment dominated around 48.9% Europe healthcare 3D printing market share in 2021, due to increasing use of 3D printing technology in the medical field. Medical applications include development of surgical implants that are utilized for patients to recover from the accidents. Also, the use in tissue scaffold printing and cell printing are foremost techniques for reconstructing human organs. Moreover, bioprinting is also used to create more accurate non-biologic and biologic research tools for research purposes in various applications.

Europe Market, By Country

Germany healthcare 3D printing market will showcase around 21.5% growth rate during the forecast timeframe, attributed to the widespread usage, research program and technological innovation of the 3D printing technology in medical field. For instance, a German institute created blood vessels with the use of artificial biological cell, a laser, and a 3D inkjet printer for molding them. Likewise, researchers at the University of Rostock in Germany, Harvard Medical Institute and the University of Sydney are developing methods of heart repair, or types of a heart patch, made with 3D printed cells.

Competitive Industry Landscape

Major players involved in the Europe healthcare 3D printing market are Envision TEC, Luxexel, Materialise NV, Stratasys Ltd, 3D Bioprinting Solutions, regenHU and Renishaw. Companies adopt various organic and inorganic growth strategies such as mergers, acquisition, partnership, novel product launch to consolidate their market position and strengthen their regional penetration.

For instance, in March 2022, 3D Systems announced that it has entered into an agreement to acquire Kumovis, a Munich, Germany-based additive manufacturing solutions provider for personalized healthcare applications. With this acquisition, 3D Systems is expected to add a unique extrusion technology to its extensive polymer 3D printing healthcare portfolio, allowing the company to expand its addressable market for personalized healthcare applications.